Annals of Oncology Advance Access published online on July 12, 2005
Annals of Oncology, doi:10.1093/annonc/mdi357
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Department of Haematology, University of Florence, Azienda Ospedaliera Careggi, Florence, Italy
* To whom correspondence should be addressed.
Letter to the Editor
Pulmonary hypertension related to thalidomide therapy in refractory multiple myeloma
2 Department of Oncology, General Hospital S.Giuseppe, Empoli, Florence, Italy
3 Department of Medicine, General Hospital S.Giuseppe, Empoli, Florence, Italy
C. Nozzoli, E-mail: c.nozzoli{at}dac.unifi.it
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
H. A. Ghofrani, R. J. Barst, R. L. Benza, H. C. Champion, K. A. Fagan, F. Grimminger, M. Humbert, G. Simonneau, D. J. Stewart, C. Ventura, et al. Future perspectives for the treatment of pulmonary arterial hypertension. J. Am. Coll. Cardiol., June 30, 2009; 54(1 Suppl): S108 - S117. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lafaras, E. Mandala, E. Verrou, D. Platogiannis, N. Barbetakis, T. Bischiniotis, and K. Zervas Non-thromboembolic pulmonary hypertension in multiple myeloma, after thalidomide treatment: A pilot study Ann. Onc., October 1, 2008; 19(10): 1765 - 1769. [Abstract] [Full Text] [PDF] |
||||

